Infective endocarditis caused by daptomycin-resistant Enterococcus faecalis: A case report

Scandinavian Journal of Infectious Diseases

Volumn 39, Issue 1, 2007, Pages 75-77

  Kanafani, Zeina A ^a   Federspiel, Jerome J ^a   Fowler Jr , Vance G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; DAPTOMYCIN; GENTAMICIN; PENICILLIN G; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIUM ISOLATE; BLOOD CULTURE; CASE REPORT; CATHETER COMPLICATION; CHILL; DEFIBRILLATOR; DESENSITIZATION; DEVICE REMOVAL; DIABETES MELLITUS; DRUG HYPERSENSITIVITY; ECCHYMOSIS; ENTEROCOCCUS FAECALIS; FEMALE; FEVER; HEART MURMUR; HEMODIALYSIS PATIENT; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SKIN EDEMA; SURGICAL DRAINAGE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VALVULOPLASTY;

AMPICILLIN; ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERS, INDWELLING; DAPTOMYCIN; DRUG RESISTANCE, BACTERIAL; ENDOCARDITIS, BACTERIAL; ENTEROCOCCUS FAECALIS; FEMALE; GENTAMICINS; HUMANS; MIDDLE AGED;

EID: 33847217648     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540600786465     Document Type: Article

References (12)

1. Fenton, C., Keating, GM and Curran, MP. (2004) Daptomycin. Drugs, 64, pp. 445-455.
2. Jevitt, LA, Smith, AJ, Williams, PP, Raney, PM, McGowan Jr, JE and Tenover, FC. (2003) In vitro activities of daptomycin, linezolid, and quinupristin-dalfopristin against a challenge panel of staphylococci and enterococci, including vancomycin-intermediate Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. Microb Drug Resist, 9, pp. 389-393.
3. Mangili, A., Bica, I., Snydman, DR and Hamer, DH. (2005) Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis, 40, pp. 1058-1060.
4. Streit, JM, Jones, RN and Sader, HS. (2004) Daptomycin activity and spectrum: A worldwide sample of 6737 clinical Gram-positive organisms. J Antimicrob Chemother, 53, pp. 669-674.
5. Fluit, AC, Schmitz, FJ, Verhoef, J. and Milatovic, D. (2004) Daptomycin in vitro susceptibility in European Gram-positive clinical isolates. Int J Antimicrob Agents, 24, pp. 59-66.
6. Sader, HS, Streit, JM, Fritsche, TR and Jones, RN. (2004) Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide. Diagn Microbiol Infect Dis, 50, pp. 201-204.
7. Munoz-Price, LS, Lolans, K. and Quinn, JP. (2005) Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection. Clin Infect Dis, 41, pp. 565-566.
8. Critchley, IA, Blosser-Middleton, RS, Jones, ME, Thornsberry, C., Sahm, DF and Karlowsky, JA. (2047) Baseline study to determine in vitro activities of daptomycin against Gram-positive pathogens isolated in the United States in 2000-2001. Antimicrob Agents Chemother, 2003, pp. 1689-1693.
9. Critchley, IA, Draghi, DC, Sahm, DF, Thornsberry, C., Jones, ME and Karlowsky, JA. (1951) Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001. J Antimicrob Chemother, 2003, pp. 639-649.
10. Cha, R., Grucz Jr, RG and Rybak, MJ. (2003) Daptomycin dose-effect relationship against resistant Gram-positive organisms. Antimicrob Agents Chemother, 47, pp. 1598-1603.
11. Lewis, JS II, Owens, A., Cadena, J., Sabol, K., Patterson, JE and Jorgensen, JH. (2005) Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy. Antimicrob Agents Chemother, 49, pp. 1664-1665.
12. Baddour, LM, Wilson, WR, Bayer, AS, Fowler Jr, VG, Bolger, AF and Levism, ME (2005) Infective endocarditis: Diagnosis, antimicrobial therapy, and management of complications: A statement for health care professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America. Circulation, 111, pp. 394-434.